Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure
Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure
观看 CytoSorbents;Hearing Zacks Small-Cap Research 设定了 6 美元的目标股价;CytoSorbents 公布了 2023 年第二季度的财务和经营业绩,显示产品收入强劲增长,成本结构有所改善
Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure
观看 CytoSorbents;Hearing Zacks Small-Cap Research 设定了 6 美元的目标股价;CytoSorbents 公布了 2023 年第二季度的财务和经营业绩,显示产品收入强劲增长,成本结构有所改善